Letter: A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia

Ähnliche Einträge

• A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
  von: Maral Amangurbanova, et al.
  Veröffentlicht: (2024)
• Editorial: Hyperferritinaemia—An Ironclad Biomarker for the Prognostication of MASLD?
  von: Mark C. C. Cheah, et al.
  Veröffentlicht: (2025)
• Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia—Authors' Reply
  von: Maral Amangurbanova, et al.
  Veröffentlicht: (2024)
• Letter: Bisphosphonate effectiveness in patients with cirrhosis—An emulated clinical trial
  von: Mingsi Zhang, et al.
  Veröffentlicht: (2024)
• Letter on ‘Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study’
  von: Muhammad Abubakr, et al.
  Veröffentlicht: (2025)